Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Apr;54(Suppl 1):S1–S28. doi: 10.1136/thx.54.suppl_1.s1

The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults

B T SOCIETY, S O COMMITTEE
PMCID: PMC1765921  PMID: 11006787

Full Text

The Full Text of this article is available as a PDF (267.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSEN H. A., FONTANA R. S., HARRISON E. G., Jr TRANSBRONCHOSCOPIC LUNG BIOPSY IN DIFFUSE PULMONARY DISEASE. Dis Chest. 1965 Aug;48:187–192. [PubMed] [Google Scholar]
  2. Adamson J. S., Jr, Bates J. H. Percutaneous needle biopsy of the lung. Arch Intern Med. 1967 Feb;119(2):164–169. [PubMed] [Google Scholar]
  3. Agostini C., Semenzato G. Does analysis of bronchoalveolar lavage fluid provide a tool to monitor disease progression or to predict survival in patients with HIV-1 infection? Thorax. 1994 Sep;49(9):848–851. doi: 10.1136/thx.49.9.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Agustí C., Xaubet A., Agustí A. G., Roca J., Ramirez J., Rodriguez-Roisin R. Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. Eur Respir J. 1994 Apr;7(4):643–650. doi: 10.1183/09031936.94.07040643. [DOI] [PubMed] [Google Scholar]
  5. Ahmad M., Livingston D. R., Golish J. A., Mehta A. C., Wiedemann H. P. The safety of outpatient transbronchial biopsy. Chest. 1986 Sep;90(3):403–405. doi: 10.1378/chest.90.3.403. [DOI] [PubMed] [Google Scholar]
  6. Akira M., Hamada H., Sakatani M., Kobayashi C., Nishioka M., Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol. 1997 Jan;168(1):79–83. doi: 10.2214/ajr.168.1.8976924. [DOI] [PubMed] [Google Scholar]
  7. Akoun G. M., Cadranel J. L., Rosenow E. C., 3rd, Milleron B. J. Bronchoalveolar lavage cell data in drug-induced pneumonitis. Allerg Immunol (Paris) 1991 Jun;23(6):245–252. [PubMed] [Google Scholar]
  8. Allen J. N., Davis W. B. Eosinophilic lung diseases. Am J Respir Crit Care Med. 1994 Nov;150(5 Pt 1):1423–1438. doi: 10.1164/ajrccm.150.5.7952571. [DOI] [PubMed] [Google Scholar]
  9. Andersen H. A. Transbronchoscopic lung biopsy for diffuse pulmonary diseases. Results in 939 patients. Chest. 1978 May;73(5 Suppl):734–736. [PubMed] [Google Scholar]
  10. Balsløv S., Vestbo J., Viskum K. A. Value of Tru-cut lung biopsy in focal and diffuse lung disease. Thorax. 1988 Feb;43(2):147–150. doi: 10.1136/thx.43.2.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Barzó P. Familial idiopathic fibrosing alveolitis. Eur J Respir Dis. 1985 May;66(5):350–352. [PubMed] [Google Scholar]
  12. Basset F., Soler P., Jaurand M. C., Bignon J. Ultrastructural examination of broncho-alveolar lavage for diagnosis of pulmonary histiocytosis X: Preliminary report on 4 cases. Thorax. 1977 Jun;32(3):303–306. doi: 10.1136/thx.32.3.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Baughman R. P., Shipley R. T., Loudon R. G., Lower E. E. Crackles in interstitial lung disease. Comparison of sarcoidosis and fibrosing alveolitis. Chest. 1991 Jul;100(1):96–101. doi: 10.1378/chest.100.1.96. [DOI] [PubMed] [Google Scholar]
  14. Baughman R. P. Use of bronchoscopy in the diagnosis of infection in the immunocompromised host. Thorax. 1994 Jan;49(1):3–7. doi: 10.1136/thx.49.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Behr J., Vogelmeier C., Beinert T., Meurer M., Krombach F., König G., Fruhmann G. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):400–406. doi: 10.1164/ajrccm.154.2.8756813. [DOI] [PubMed] [Google Scholar]
  16. Bensard D. D., McIntyre R. C., Jr, Waring B. J., Simon J. S. Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease. Chest. 1993 Mar;103(3):765–770. doi: 10.1378/chest.103.3.765. [DOI] [PubMed] [Google Scholar]
  17. Bentzon N., Adamsen S., Jacobsen B., Eriksen C., Hansen O. H. Videothoracoscopic lung biopsy by a stapling technique. Eur J Surg. 1994 Oct;160(10):543–546. [PubMed] [Google Scholar]
  18. Betsuyaku T., Munakata M., Yamaguchi E., Ohe S., Hizawa N., Sukoh N., Yamashiro K., Mikuni C., Kawakami Y. Establishing diagnosis of pulmonary malignant lymphoma by gene rearrangement analysis of lymphocytes in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):526–529. doi: 10.1164/ajrccm.149.2.8306056. [DOI] [PubMed] [Google Scholar]
  19. Bigby T. D., Margolskee D., Curtis J. L., Michael P. F., Sheppard D., Hadley W. K., Hopewell P. C. The usefulness of induced sputum in the diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis. 1986 Apr;133(4):515–518. doi: 10.1164/arrd.1986.133.4.515. [DOI] [PubMed] [Google Scholar]
  20. Bjermer L., Thunell M., Rosenhall L., Stjernberg N. Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir Med. 1991 May;85(3):229–234. doi: 10.1016/s0954-6111(06)80085-5. [DOI] [PubMed] [Google Scholar]
  21. Bourke S. J., Banham S. W., McKillop J. H., Boyd G. Clearance of 99mTc-DTPA in pigeon fancier's hypersensitivity pneumonitis. Am Rev Respir Dis. 1990 Nov;142(5):1168–1171. doi: 10.1164/ajrccm/142.5.1168. [DOI] [PubMed] [Google Scholar]
  22. Boylen C. T., Johnson N. R., Richters V., Balchum O. J. High speed trephine lung biopsy: methods and results. Chest. 1973 Jan;63(1):59–62. doi: 10.1378/chest.63.1.59. [DOI] [PubMed] [Google Scholar]
  23. Brådvik I., Wollmer P., Evander E., Lárusdóttir H., Blom-Bülow B., Jonson B. Different kinetics of lung clearance of technetium-99m labelled diethylene triamine penta-acetic acid in patients with sarcoidosis and smokers. Eur J Nucl Med. 1994 Nov;21(11):1218–1222. doi: 10.1007/BF00182356. [DOI] [PubMed] [Google Scholar]
  24. Burrell R., Rylander R. A critical review of the role of precipitins in hypersensitivity pneumonitis. Eur J Respir Dis. 1981 Oct;62(5):332–343. [PubMed] [Google Scholar]
  25. Burt M. E., Flye M. W., Webber B. L., Wesley R. A. Prospective evaluation of aspiration needle, cutting needle, transbronchial, and open lung biopsy in patients with pulmonary infiltrates. Ann Thorac Surg. 1981 Aug;32(2):146–153. doi: 10.1016/s0003-4975(10)61021-1. [DOI] [PubMed] [Google Scholar]
  26. Carnochan F. M., Walker W. S., Cameron E. W. Efficacy of video assisted thoracoscopic lung biopsy: an historical comparison with open lung biopsy. Thorax. 1994 Apr;49(4):361–363. doi: 10.1136/thx.49.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Carrington C. B., Gaensler E. A., Coutu R. E., FitzGerald M. X., Gupta R. G. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med. 1978 Apr 13;298(15):801–809. doi: 10.1056/NEJM197804132981501. [DOI] [PubMed] [Google Scholar]
  28. Castillo G., Ahmad M., VanOrdstrand H. S., McCormack L. J. Trephine drill biopsy of the lung. Cleveland clinic experience. JAMA. 1974 Apr 8;228(2):189–191. [PubMed] [Google Scholar]
  29. Chechani V., Landreneau R. J., Shaikh S. S. Open lung biopsy for diffuse infiltrative lung disease. Ann Thorac Surg. 1992 Aug;54(2):296–300. doi: 10.1016/0003-4975(92)91388-p. [DOI] [PubMed] [Google Scholar]
  30. Cherniack R. M., Colby T. V., Flint A., Thurlbeck W. M., Waldron J., Ackerson L., King T. E., Jr Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1991 Oct;144(4):892–900. doi: 10.1164/ajrccm/144.4.892. [DOI] [PubMed] [Google Scholar]
  31. Chinet T., Dusser D., Labrune S., Collignon M. A., Chrétien J., Huchon G. J. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA. Am Rev Respir Dis. 1990 Feb;141(2):445–449. doi: 10.1164/ajrccm/141.2.445. [DOI] [PubMed] [Google Scholar]
  32. Chinet T., Jaubert F., Dusser D., Danel C., Chrétien J., Huchon G. J. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax. 1990 Sep;45(9):675–678. doi: 10.1136/thx.45.9.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Chouaid C., Maillard D., Housset B., Febvre M., Zaoui D., Lebeau B. Cost effectiveness of noninvasive oxygen saturation measurement during exercise for the diagnosis of Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1360–1363. doi: 10.1164/ajrccm/147.6_Pt_1.1360. [DOI] [PubMed] [Google Scholar]
  34. Churg A. An inflation procedure for open lung biopsies. Am J Surg Pathol. 1983 Jan;7(1):69–71. doi: 10.1097/00000478-198301000-00007. [DOI] [PubMed] [Google Scholar]
  35. Coleman D. L., Hattner R. S., Luce J. M., Dodek P. M., Golden J. A., Murray J. F. Correlation between gallium lung scans and fiberoptic bronchoscopy in patients with suspected Pneumocystis carinii pneumonia and the acquired immune deficiency syndrome. Am Rev Respir Dis. 1984 Dec;130(6):1166–1169. doi: 10.1164/arrd.1984.130.6.1166. [DOI] [PubMed] [Google Scholar]
  36. Collins C. D., Wells A. U., Hansell D. M., Morgan R. A., MacSweeney J. E., du Bois R. M., Rubens M. B. Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol. 1994 Apr;49(4):236–240. doi: 10.1016/s0009-9260(05)81847-1. [DOI] [PubMed] [Google Scholar]
  37. Cooper J. A., Jr, White D. A., Matthay R. A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis. 1986 Feb;133(2):321–340. doi: 10.1164/arrd.1986.133.2.321. [DOI] [PubMed] [Google Scholar]
  38. Cooper J. A., Jr, White D. A., Matthay R. A. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. Am Rev Respir Dis. 1986 Mar;133(3):488–505. doi: 10.1164/arrd.1986.133.3.488. [DOI] [PubMed] [Google Scholar]
  39. Costabel U., Donner C. F., Haslam P. L., Rizzato G., Teschler H., Velluti G., Wallaert B. Clinical guidelines and indications for bronchoalveolar lavage (BAL): occupational lung diseases due to inhalation of inorganic dust. Eur Respir J. 1990 Sep;3(8):946-9, 961-9. [PubMed] [Google Scholar]
  40. Costello J. F., Moriarty D. C., Branthwaite M. A., Turner-Warwick M., Corrin B. Diagnosis and management of alveolar proteinosis: the rôle of electron microscopy. Thorax. 1975 Apr;30(2):121–132. doi: 10.1136/thx.30.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Coudert B., Bailly F., Lombard J. N., Andre F., Camus P. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature. Chest. 1992 Oct;102(4):1005–1012. doi: 10.1378/chest.102.4.1005. [DOI] [PubMed] [Google Scholar]
  42. Coultas D. B., Zumwalt R. E., Black W. C., Sobonya R. E. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994 Oct;150(4):967–972. doi: 10.1164/ajrccm.150.4.7921471. [DOI] [PubMed] [Google Scholar]
  43. Coutts I. I., Gilson J. C., Kerr I. H., Parkes W. R., Turner-Warwick M. Significance of finger clubbing in asbestosis. Thorax. 1987 Feb;42(2):117–119. doi: 10.1136/thx.42.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Crausman R. S., Jennings C. A., Tuder R. M., Ackerson L. M., Irvin C. G., King T. E., Jr Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med. 1996 Jan;153(1):426–435. doi: 10.1164/ajrccm.153.1.8542154. [DOI] [PubMed] [Google Scholar]
  45. Crystal R. G., Bitterman P. B., Rennard S. I., Hance A. J., Keogh B. A. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med. 1984 Jan 19;310(3):154–166. doi: 10.1056/NEJM198401193100304. [DOI] [PubMed] [Google Scholar]
  46. Crystal R. G., Fulmer J. D., Roberts W. C., Moss M. L., Line B. R., Reynolds H. Y. Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med. 1976 Dec;85(6):769–788. doi: 10.7326/0003-4819-85-6-769. [DOI] [PubMed] [Google Scholar]
  47. Curley F. J., Johal J. S., Burke M. E., Fraire A. E. Transbronchial lung biopsy: can specimen quality be predicted at the time of biopsy? Chest. 1998 Apr;113(4):1037–1041. doi: 10.1378/chest.113.4.1037. [DOI] [PubMed] [Google Scholar]
  48. DUTRA F. R., GERACI C. L. Needle biopsy of the lung. J Am Med Assoc. 1954 May 1;155(1):21–24. doi: 10.1001/jama.1954.03690190027008. [DOI] [PubMed] [Google Scholar]
  49. Davison A. G., Haslam P. L., Corrin B., Coutts I. I., Dewar A., Riding W. D., Studdy P. R., Newman-Taylor A. J. Interstitial lung disease and asthma in hard-metal workers: bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation tests. Thorax. 1983 Feb;38(2):119–128. doi: 10.1136/thx.38.2.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Davison A. G., Heard B. E., McAllister W. A., Turner-Warwick M. E. Cryptogenic organizing pneumonitis. Q J Med. 1983 Summer;52(207):382–394. [PubMed] [Google Scholar]
  51. Delobbe A., Durieu J., Duhamel A., Wallaert B. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord. Eur Respir J. 1996 Oct;9(10):2002–2006. doi: 10.1183/09031936.96.09102002. [DOI] [PubMed] [Google Scholar]
  52. Descombes E., Gardiol D., Leuenberger P. Transbronchial lung biopsy: an analysis of 530 cases with reference to the number of samples. Monaldi Arch Chest Dis. 1997 Aug;52(4):324–329. [PubMed] [Google Scholar]
  53. Dina R., Sheppard M. N. The histological diagnosis of clinically documented cases of cryptogenic organizing pneumonia: diagnostic features in transbronchial biopsies. Histopathology. 1993 Dec;23(6):541–545. doi: 10.1111/j.1365-2559.1993.tb01240.x. [DOI] [PubMed] [Google Scholar]
  54. Donaghy M., Rees A. J. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet. 1983 Dec 17;2(8364):1390–1393. doi: 10.1016/s0140-6736(83)90923-6. [DOI] [PubMed] [Google Scholar]
  55. Drent M., Wagenaar S. S., Mulder P. H., van Velzen-Blad H., Diamant M., van den Bosch J. M. Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis, and non-Hodgkin's and Hodgkin's disease. An evaluation of differences. Chest. 1994 Feb;105(2):514–519. doi: 10.1378/chest.105.2.514. [DOI] [PubMed] [Google Scholar]
  56. Drent M., van Nierop M. A., Gerritsen F. A., Wouters E. F., Mulder P. G. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med. 1996 Feb;153(2):736–741. doi: 10.1164/ajrccm.153.2.8564126. [DOI] [PubMed] [Google Scholar]
  57. Du Bois R. M., McAllister W. A., Branthwaite M. A. Alveolar proteinosis: diagnosis and treatment over a 10-year period. Thorax. 1983 May;38(5):360–363. doi: 10.1136/thx.38.5.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Dusser D. J., Collignon M. A., Stanislas-Leguern G., Barritault L. G., Chrétien J., Huchon G. J. Respiratory clearance of 99mTc-DTPA and pulmonary involvement in sarcoidosis. Am Rev Respir Dis. 1986 Sep;134(3):493–497. doi: 10.1164/arrd.1986.134.3.493. [DOI] [PubMed] [Google Scholar]
  59. Ellis J. H., Jr Transbronchial lung biopsy via the fiberoptic bronchoscope. Experience with 107 consecutive cases and comparison with bronchial brushing. Chest. 1975 Oct;68(4):524–532. doi: 10.1378/chest.68.4.524. [DOI] [PubMed] [Google Scholar]
  60. Epler G. R., Carrington C. B., Gaensler E. A. Crackles (rales) in the interstitial pulmonary diseases. Chest. 1978 Mar;73(3):333–339. doi: 10.1378/chest.73.3.333. [DOI] [PubMed] [Google Scholar]
  61. Erbes R., Schaberg T., Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest. 1997 Jan;111(1):51–57. doi: 10.1378/chest.111.1.51. [DOI] [PubMed] [Google Scholar]
  62. Fanti S., De Fabritiis A., Aloisi D., Dondi M., Marengo M., Compagnone G., Fallani F., Cavalli A., Monetti N. Early pulmonary involvement in systemic sclerosis assessed by technetium-99m-DTPA clearance rate. J Nucl Med. 1994 Dec;35(12):1933–1936. [PubMed] [Google Scholar]
  63. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
  64. Fechner R. E., Greenberg S. D., Wilson R. K., Stevens P. M. Evaluation of transbronchial biopsy of the lung. Am J Clin Pathol. 1977 Jul;68(1):17–20. doi: 10.1093/ajcp/68.1.17. [DOI] [PubMed] [Google Scholar]
  65. Fink J. N., Schlueter D. P., Sosman A. J., Unger G. F., Barboriak J. J., Rimm A. A., Arkins J. A., Dhaliwal K. S. Clinical survey of pigeon breeders. Chest. 1972 Sep;62(3):277–281. doi: 10.1378/chest.62.3.277. [DOI] [PubMed] [Google Scholar]
  66. Forni A. Bronchoalveolar lavage in the diagnosis of hard metal disease. Sci Total Environ. 1994 Jun 30;150(1-3):69–76. doi: 10.1016/0048-9697(94)90131-7. [DOI] [PubMed] [Google Scholar]
  67. Fulmer J. D., Roberts W. C., von Gal E. R., Crystal R. G. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest. 1979 Apr;63(4):665–676. doi: 10.1172/JCI109349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. GAENSLER E. A., MOISTER V. B., HAMM J. OPEN-LUNG BIOPSY IN DUFFUSE PULMONARY DISEASE. N Engl J Med. 1964 Jun 18;270:1319–1331. doi: 10.1056/NEJM196406182702501. [DOI] [PubMed] [Google Scholar]
  69. Gaensler E. A., Carrington C. B. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg. 1980 Nov;30(5):411–426. doi: 10.1016/s0003-4975(10)61291-x. [DOI] [PubMed] [Google Scholar]
  70. Gaensler E. A., Carrington C. B. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg. 1980 Nov;30(5):411–426. doi: 10.1016/s0003-4975(10)61291-x. [DOI] [PubMed] [Google Scholar]
  71. Gay S. E., Kazerooni E. A., Toews G. B., Lynch J. P., 3rd, Gross B. H., Cascade P. N., Spizarny D. L., Flint A., Schork M. A., Whyte R. I. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1063–1072. doi: 10.1164/ajrccm.157.4.9703022. [DOI] [PubMed] [Google Scholar]
  72. Gibson G. J., Prescott R. J., Muers M. F., Middleton W. G., Mitchell D. N., Connolly C. K., Harrison B. D. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax. 1996 Mar;51(3):238–247. doi: 10.1136/thx.51.3.238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Gilman M. J., Wang K. P. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis. 1980 Nov;122(5):721–724. doi: 10.1164/arrd.1980.122.5.721. [DOI] [PubMed] [Google Scholar]
  74. Goldstein D. S., Williams M. H. Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids. Thorax. 1986 Jun;41(6):473–474. doi: 10.1136/thx.41.6.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Grenier P., Chevret S., Beigelman C., Brauner M. W., Chastang C., Valeyre D. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology. 1994 May;191(2):383–390. doi: 10.1148/radiology.191.2.8153310. [DOI] [PubMed] [Google Scholar]
  76. Grenier P., Valeyre D., Cluzel P., Brauner M. W., Lenoir S., Chastang C. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology. 1991 Apr;179(1):123–132. doi: 10.1148/radiology.179.1.2006262. [DOI] [PubMed] [Google Scholar]
  77. Gulsvik A., Kjelsberg F., Bergmann A., Frøland S. S., Rootwelt K., Vale J. R. High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study. Respiration. 1986;50(4):252–257. doi: 10.1159/000194935. [DOI] [PubMed] [Google Scholar]
  78. Hanley M. E., King T. E., Jr, Schwarz M. I., Watters L. C., Shen A. S., Cherniack R. M. The impact of smoking on mechanical properties of the lungs in idiopathic pulmonary fibrosis and sarcoidosis. Am Rev Respir Dis. 1991 Nov;144(5):1102–1106. doi: 10.1164/ajrccm/144.5.1102. [DOI] [PubMed] [Google Scholar]
  79. Hansell D. M., Wells A. U. CT evaluation of fibrosing alveolitis--applications and insights. J Thorac Imaging. 1996 Fall;11(4):231–249. doi: 10.1097/00005382-199623000-00001. [DOI] [PubMed] [Google Scholar]
  80. Hanson D., Winterbauer R. H., Kirtland S. H., Wu R. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest. 1995 Aug;108(2):305–310. doi: 10.1378/chest.108.2.305. [DOI] [PubMed] [Google Scholar]
  81. Haponik E. F., Summer W. R., Terry P. B., Wang K. P. Clinical decision making with transbronchial lung biopsies. The value of nonspecific histologic examination. Am Rev Respir Dis. 1982 May;125(5):524–529. doi: 10.1164/arrd.1982.125.5.524. [DOI] [PubMed] [Google Scholar]
  82. Harris R. J., Kavuru M. S., Rice T. W., Kirby T. J. The diagnostic and therapeutic utility of thoracoscopy. A review. Chest. 1995 Sep;108(3):828–841. doi: 10.1378/chest.108.3.828. [DOI] [PubMed] [Google Scholar]
  83. Harrison B. D., Shaylor J. M., Stokes T. C., Wilkes A. R. Airflow limitation in sarcoidosis--a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med. 1991 Jan;85(1):59–64. doi: 10.1016/s0954-6111(06)80211-8. [DOI] [PubMed] [Google Scholar]
  84. Harrison N. K., Glanville A. R., Strickland B., Haslam P. L., Corrin B., Addis B. J., Lawrence R., Millar A. B., Black C. M., Turner-Warwick M. Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Respir Med. 1989 Sep;83(5):403–414. doi: 10.1016/s0954-6111(89)80072-1. [DOI] [PubMed] [Google Scholar]
  85. Haslam P. L., Poulter L. W., Rossi G. A., Bauer W., De Rose V., Eckert H., Olivieri D., Teschler H. The clinical role of BAL in idiopathic pulmonary fibrosis. Eur Respir J. 1990 Sep;3(8):940-2, 961-9. [PubMed] [Google Scholar]
  86. Haslam P. L., Turton C. W., Lukoszek A., Salsbury A. J., Dewar A., Collins J. V., Turner-Warwick M. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax. 1980 May;35(5):328–339. doi: 10.1136/thx.35.5.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Herf S. M., Suratt P. M., Arora N. S. Deaths and complications associated with transbronchial lung biopsy. Am Rev Respir Dis. 1977 Apr;115(4):708–711. doi: 10.1164/arrd.1977.115.4.708. [DOI] [PubMed] [Google Scholar]
  88. Hill C., Romas E., Kirkham B. Use of sequential DTPA clearance and high resolution computerized tomography in monitoring interstitial lung disease in dermatomyositis. Br J Rheumatol. 1996 Feb;35(2):164–166. doi: 10.1093/rheumatology/35.2.164. [DOI] [PubMed] [Google Scholar]
  89. Huang C. T., Heurich A. E., Rosen Y., Moon S., Lyons H. A. Pulmonary sarcoidosis: roentgenographic, functional, and pathologic correlations. Respiration. 1979;37(6):337–345. doi: 10.1159/000194046. [DOI] [PubMed] [Google Scholar]
  90. Hyde D. M., King T. E., Jr, McDermott T., Waldron J. A., Jr, Colby T. V., Thurlbeck W. M., Flint W. M., Ackerson L., Cherniack R. M. Idiopathic pulmonary fibrosis. Quantitative assessment of lung pathology. Comparison of a semiquantitative and a morphometric histopathologic scoring system. Am Rev Respir Dis. 1992 Oct;146(4):1042–1047. doi: 10.1164/ajrccm/146.4.1042. [DOI] [PubMed] [Google Scholar]
  91. Hällgren R., Bjermer L., Lundgren R., Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis. 1989 Feb;139(2):373–377. doi: 10.1164/ajrccm/139.2.373. [DOI] [PubMed] [Google Scholar]
  92. Jacobs M. P., Baughman R. P., Hughes J., Fernandez-Ulloa M. Radioaerosol lung clearance in patients with active pulmonary sarcoidosis. Am Rev Respir Dis. 1985 May;131(5):687–689. doi: 10.1164/arrd.1985.131.5.687. [DOI] [PubMed] [Google Scholar]
  93. Jezek V., Fucik J., Michaljanic A., Jezkova L. The prognostic significance of functional tests in cryptogenic fibrosing alveolitis. Bull Eur Physiopathol Respir. 1980 Nov-Dec;16(6):711–720. [PubMed] [Google Scholar]
  94. Johnson M. A., Kwan S., Snell N. J., Nunn A. J., Darbyshire J. H., Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax. 1989 Apr;44(4):280–288. doi: 10.1136/thx.44.4.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Johnston I. D., Gomm S. A., Kalra S., Woodcock A. A., Evans C. C., Hind C. R. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Respir J. 1993 Jun;6(6):891–893. [PubMed] [Google Scholar]
  96. Johnston I. D., Prescott R. J., Chalmers J. C., Rudd R. M. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax. 1997 Jan;52(1):38–44. doi: 10.1136/thx.52.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Johnston I., Britton J., Kinnear W., Logan R. Rising mortality from cryptogenic fibrosing alveolitis. BMJ. 1990 Nov 3;301(6759):1017–1021. doi: 10.1136/bmj.301.6759.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Jones J. G., Minty B. D., Lawler P., Hulands G., Crawley J. C., Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet. 1980 Jan 12;1(8159):66–68. doi: 10.1016/s0140-6736(80)90493-6. [DOI] [PubMed] [Google Scholar]
  99. Joyner L. R., Scheinhorn D. J. Transbronchial forceps lung biopsy through the fiberoptic bronchoscope. tdiagnosis of diffuse pulmonary disease. Chest. 1975 May;67(5):532–535. doi: 10.1378/chest.67.5.532. [DOI] [PubMed] [Google Scholar]
  100. Kao C. H., Lin H. T., Yu S. L., Wang S. J., Yeh S. H. Relationship of alveolar permeability and lung inflammation in patients with active diffuse infiltrative lung disease detected by 99Tcm-DTPA radioaerosol inhalation lung scintigraphy and quantitative 67Ga lung scans. Nucl Med Commun. 1994 Oct;15(10):850–854. doi: 10.1097/00006231-199410000-00012. [DOI] [PubMed] [Google Scholar]
  101. Katzenstein A. L., Myers J. L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1301–1315. doi: 10.1164/ajrccm.157.4.9707039. [DOI] [PubMed] [Google Scholar]
  102. Keogh B. A., Bernardo J., Hunninghake G. W., Line B. R., Price D. L., Crystal R. G. Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1983 Jan;127(1):18–22. doi: 10.1164/arrd.1983.127.1.18. [DOI] [PubMed] [Google Scholar]
  103. Keogh B. A., Crystal R. G. Clinical significance of pulmonary function tests. Pulmonary function testing in interstitial pulmonary disease. What does it tell us? Chest. 1980 Dec;78(6):856–865. doi: 10.1378/chest.78.6.856. [DOI] [PubMed] [Google Scholar]
  104. Keogh B. A., Hunninghake G. W., Line B. R., Crystal R. G. The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function. Am Rev Respir Dis. 1983 Aug;128(2):256–265. doi: 10.1164/arrd.1983.128.2.256. [DOI] [PubMed] [Google Scholar]
  105. King T. E., Jr, Mortenson R. L. Bronchoalveolar lavage in patients with connective tissue disease. J Thorac Imaging. 1992 Jun;7(3):26–48. doi: 10.1097/00005382-199206000-00005. [DOI] [PubMed] [Google Scholar]
  106. Kitaichi M., Nishimura K., Itoh H., Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):527–533. doi: 10.1164/ajrccm.151.2.7842216. [DOI] [PubMed] [Google Scholar]
  107. Krasna M. J., White C. S., Aisner S. C., Templeton P. A., McLaughlin J. S. The role of thoracoscopy in the diagnosis of interstitial lung disease. Ann Thorac Surg. 1995 Feb;59(2):348–351. doi: 10.1016/0003-4975(94)00844-w. [DOI] [PubMed] [Google Scholar]
  108. Kusaka H., Homma Y., Ogasawara H., Munakata M., Tanimura K., Ukita H., Denzumi N., Kawakami Y. Five-year follow-up of Micropolyspora faeni antibody in smoking and nonsmoking farmers. Am Rev Respir Dis. 1989 Sep;140(3):695–699. doi: 10.1164/ajrccm/140.3.695. [DOI] [PubMed] [Google Scholar]
  109. Labrune S., Chinet T., Collignon M. A., Barritault L., Huchon G. J. Mechanisms of increased epithelial lung clearance of DTPA in diffuse fibrosing alveolitis. Eur Respir J. 1994 Apr;7(4):651–656. doi: 10.1183/09031936.94.07040651. [DOI] [PubMed] [Google Scholar]
  110. Lawrence E. C., Teague R. B., Gottlieb M. S., Jhingran S. G., Lieberman J. Serial changes in markers of disease activity with corticosteroid treatment in sarcoidosis. Am J Med. 1983 May;74(5):747–756. doi: 10.1016/0002-9343(83)91062-8. [DOI] [PubMed] [Google Scholar]
  111. Leblond V., Zouabi H., Sutton L., Guillon J. M., Mayaud C. M., Similowski T., Beigelman C., Autran B. Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease. Am J Respir Crit Care Med. 1994 Oct;150(4):1056–1061. doi: 10.1164/ajrccm.150.4.7921436. [DOI] [PubMed] [Google Scholar]
  112. Lee J. S., Im J. G., Ahn J. M., Kim Y. M., Han M. C. Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT. Radiology. 1992 Aug;184(2):451–454. doi: 10.1148/radiology.184.2.1620846. [DOI] [PubMed] [Google Scholar]
  113. Lee K. S., Primack S. L., Staples C. A., Mayo J. R., Aldrich J. E., Müller N. L. Chronic infiltrative lung disease: comparison of diagnostic accuracies of radiography and low- and conventional-dose thin-section CT. Radiology. 1994 Jun;191(3):669–673. doi: 10.1148/radiology.191.3.8184044. [DOI] [PubMed] [Google Scholar]
  114. Leung A. N., Miller R. R., Müller N. L. Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation. Radiology. 1993 Jul;188(1):209–214. doi: 10.1148/radiology.188.1.8511299. [DOI] [PubMed] [Google Scholar]
  115. Line B. R., Fulmer J. D., Reynolds H. Y., Roberts W. C., Jones A. E., Harris E. K., Crystal R. G. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: Correlation and physiologic and morphologic features and bronchoalveolar lavage. Am Rev Respir Dis. 1978 Aug;118(2):355–365. doi: 10.1164/arrd.1978.118.2.355. [DOI] [PubMed] [Google Scholar]
  116. Line B. R., Hunninghake G. W., Keogh B. A., Jones A. E., Johnston G. S., Crystal R. G. Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):440–446. doi: 10.1164/arrd.1981.123.4.440. [DOI] [PubMed] [Google Scholar]
  117. Lohela P., Tikkakoski T., Ammälä K., Strengell L., Suramo I., Repo U. K. Diagnosis of diffuse lung disease by cutting needle biopsy. Acta Radiol. 1994 May;35(3):251–254. [PubMed] [Google Scholar]
  118. MORRISON R., DEELEY T. J. Drill biopsy in intrathoracic malignant disease. Thorax. 1957 Mar;12(1):87–90. doi: 10.1136/thx.12.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Mapel D. W., Samet J. M., Coultas D. B. Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future. Chest. 1996 Oct;110(4):1058–1067. doi: 10.1378/chest.110.4.1058. [DOI] [PubMed] [Google Scholar]
  120. Marchandise F. X., Vandenplas O., Wallon J., Francis C. Thoracoscopic lung biopsy in interstitial lung disease. Acta Clin Belg. 1992;47(3):165–169. doi: 10.1080/17843286.1992.11718226. [DOI] [PubMed] [Google Scholar]
  121. Marciniuk D. D., Gallagher C. G. Clinical exercise testing in interstitial lung disease. Clin Chest Med. 1994 Jun;15(2):287–303. [PubMed] [Google Scholar]
  122. Martin R. J., Coalson J. J., Rogers R. M., Horton F. O., Manous L. E. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis. 1980 May;121(5):819–825. doi: 10.1164/arrd.1980.121.5.819. [DOI] [PubMed] [Google Scholar]
  123. Mason G. R., Uszler J. M., Effros R. M., Reid E. Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking. Chest. 1983 Jan;83(1):6–11. doi: 10.1378/chest.83.1.6. [DOI] [PubMed] [Google Scholar]
  124. Mathieson J. R., Mayo J. R., Staples C. A., Müller N. L. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology. 1989 Apr;171(1):111–116. doi: 10.1148/radiology.171.1.2928513. [DOI] [PubMed] [Google Scholar]
  125. Mayo J. R., Jackson S. A., Müller N. L. High-resolution CT of the chest: radiation dose. AJR Am J Roentgenol. 1993 Mar;160(3):479–481. doi: 10.2214/ajr.160.3.8430539. [DOI] [PubMed] [Google Scholar]
  126. McLoud T. C., Carrington C. B., Gaensler E. A. Diffuse infiltrative lung disease: a new scheme for description. Radiology. 1983 Nov;149(2):353–363. doi: 10.1148/radiology.149.2.6622676. [DOI] [PubMed] [Google Scholar]
  127. Miller A., Brown L. K., Sloane M. F., Bhuptani A., Teirstein A. S. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest. 1995 Feb;107(2):323–329. doi: 10.1378/chest.107.2.323. [DOI] [PubMed] [Google Scholar]
  128. Miller R. F., Mitchell D. M. AIDS and the lung: update 1995. 1. Pneumocystis carinii pneumonia. Thorax. 1995 Feb;50(2):191–200. doi: 10.1136/thx.50.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Miller R. R., Nelems B., Müller N. L., Evans K. G., Ostrow D. N. Lingular and right middle lobe biopsy in the assessment of diffuse lung disease. Ann Thorac Surg. 1987 Sep;44(3):269–273. doi: 10.1016/s0003-4975(10)62071-1. [DOI] [PubMed] [Google Scholar]
  130. Milman N., Graudal N., Jacobsen G. K. Bronchoalveolar lavage in radiologically detected diffuse lung disease. Diagnostic value of total and differential cell count in a series of 130 patients. APMIS. 1995 Oct;103(10):764–768. [PubMed] [Google Scholar]
  131. Mitchell D. M., Emerson C. J., Collins J. V., Stableforth D. E. Transbronchial lung biopsy with the fibreoptic bronchoscope: analysis of results in 433 patients. Br J Dis Chest. 1981 Jul;75(3):258–262. doi: 10.1016/0007-0971(81)90003-6. [DOI] [PubMed] [Google Scholar]
  132. Mitchell D. M., Fleming J., Harris J. R., Shaw R. J. Serial pulmonary function tests in the diagnosis of P. carinii pneumonia. Eur Respir J. 1993 Jun;6(6):823–827. [PubMed] [Google Scholar]
  133. Mitchell D. M., Fleming J., Pinching A. J., Harris J. R., Moss F. M., Veale D., Shaw R. J. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis. 1992 Sep;146(3):745–751. doi: 10.1164/ajrccm/146.3.745. [DOI] [PubMed] [Google Scholar]
  134. Mitchell D. M., Mitchell D. N., Collins J. V., Emerson C. J. Transbronchial lung biopsy through fibreoptic bronchoscope in diagnosis of sarcoidosis. Br Med J. 1980 Mar 8;280(6215):679–681. doi: 10.1136/bmj.280.6215.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Murray J. F., Garay S. M., Hopewell P. C., Mills J., Snider G. L., Stover D. E. NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis. 1987 Feb;135(2):504–509. doi: 10.1164/arrd.1987.135.2.504. [DOI] [PubMed] [Google Scholar]
  136. Myre M., Allard S., Bernard C., Martin R. R. Clinical, functional and pathological correspondence in early stage idiopathic pulmonary fibrosis: evidence for small airway obstruction 1-2. Respiration. 1988;53(3):174–186. doi: 10.1159/000195411. [DOI] [PubMed] [Google Scholar]
  137. Müller N. L. Clinical value of high-resolution CT in chronic diffuse lung disease. AJR Am J Roentgenol. 1991 Dec;157(6):1163–1170. doi: 10.2214/ajr.157.6.1950859. [DOI] [PubMed] [Google Scholar]
  138. Müller N. L., Miller R. R., Webb W. R., Evans K. G., Ostrow D. N. Fibrosing alveolitis: CT-pathologic correlation. Radiology. 1986 Sep;160(3):585–588. doi: 10.1148/radiology.160.3.3737898. [DOI] [PubMed] [Google Scholar]
  139. Nasim A., Akhtar R. P., Spyt T. J. Video-thoracoscopic lung biopsy in diagnosis of interstitial lung disease. J R Coll Surg Edinb. 1995 Feb;40(1):22–24. [PubMed] [Google Scholar]
  140. Newman L. S., Rose C. S., Maier L. A. Sarcoidosis. N Engl J Med. 1997 Apr 24;336(17):1224–1234. doi: 10.1056/NEJM199704243361706. [DOI] [PubMed] [Google Scholar]
  141. Newman S. L., Michel R. P., Wang N. S. Lingular lung biopsy: is it representative? Am Rev Respir Dis. 1985 Nov;132(5):1084–1086. doi: 10.1164/arrd.1985.132.5.1084. [DOI] [PubMed] [Google Scholar]
  142. Nicholson A. G., Wotherspoon A. C., Diss T. C., Hansell D. M., Du Bois R., Sheppard M. N., Isaacson P. G., Corrin B. Reactive pulmonary lymphoid disorders. Histopathology. 1995 May;26(5):405–412. doi: 10.1111/j.1365-2559.1995.tb00247.x. [DOI] [PubMed] [Google Scholar]
  143. Nishimura K., Izumi T., Kitaichi M., Nagai S., Itoh H. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung diseases. Chest. 1993 Oct;104(4):1149–1155. doi: 10.1378/chest.104.4.1149. [DOI] [PubMed] [Google Scholar]
  144. O'Doherty M. J., Page C. J., Bradbeer C. S., Shahmanesh M., Edwards A., Barlow D., Bateman N. T., Croft D. N. Alveolar permeability in HIV antibody positive patients with Pneumocystis carinii pneumonia. Genitourin Med. 1987 Aug;63(4):268–270. doi: 10.1136/sti.63.4.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Padley S. P., Adler B., Müller N. L. High-resolution computed tomography of the chest: current indications. J Thorac Imaging. 1993 Summer;8(3):189–199. doi: 10.1097/00005382-199322000-00004. [DOI] [PubMed] [Google Scholar]
  146. Padley S. P., Hansell D. M., Flower C. D., Jennings P. Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin Radiol. 1991 Oct;44(4):222–226. doi: 10.1016/s0009-9260(05)80183-7. [DOI] [PubMed] [Google Scholar]
  147. Padley S., Gleeson F., Flower C. D. Review article: current indications for high resolution computed tomography scanning of the lungs. Br J Radiol. 1995 Feb;68(806):105–109. doi: 10.1259/0007-1285-68-806-105. [DOI] [PubMed] [Google Scholar]
  148. Perez T., Farre J. M., Gosset P., Wallaert B., Duquesnoy B., Voisin C., Delcambre B., Tonnel A. B. Subclinical alveolar inflammation in rheumatoid arthritis: superoxide anion, neutrophil chemotactic activity and fibronectin generation by alveolar macrophages. Eur Respir J. 1989 Jan;2(1):7–13. [PubMed] [Google Scholar]
  149. Peterson M. W., Monick M., Hunninghake G. W. Prognostic role of eosinophils in pulmonary fibrosis. Chest. 1987 Jul;92(1):51–56. doi: 10.1378/chest.92.1.51. [DOI] [PubMed] [Google Scholar]
  150. Pfitzenmeyer P., Foucher P., Piard F., Coudert B., Braud M. L., Gabez P., Lacroix S., Mabille J. P., Camus P. Nilutamide pneumonitis: a report on eight patients. Thorax. 1992 Aug;47(8):622–627. doi: 10.1136/thx.47.8.622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Pitchenik A. E., Ganjei P., Torres A., Evans D. A., Rubin E., Baier H. Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Respir Dis. 1986 Feb;133(2):226–229. doi: 10.1164/arrd.1986.133.2.226. [DOI] [PubMed] [Google Scholar]
  152. Poe R. H., Israel R. H., Utell M. J., Hall W. J. Probability of a positive transbronchial lung biopsy result in sarcoidosis. Arch Intern Med. 1979 Jul;139(7):761–763. [PubMed] [Google Scholar]
  153. Puar H. S., Young R. C., Jr, Armstrong E. M. Bronchial and transbronchial lung biopsy without fluoroscopy in sarcoidosis. Chest. 1985 Mar;87(3):303–306. doi: 10.1378/chest.87.3.303. [DOI] [PubMed] [Google Scholar]
  154. Ramirez-Rivera J., Liebman M., Bartone J. C. Pulmonary alveolar proteinosis. Diagnostic and pathologic implications of pulmonary washings. Am J Clin Pathol. 1966 Apr;45(4):415–419. doi: 10.1093/ajcp/45.4.415. [DOI] [PubMed] [Google Scholar]
  155. Ravini M., Ferraro G., Barbieri B., Colombo P., Rizzato G. Changing strategies of lung biopsies in diffuse lung diseases: the impact of video-assisted thoracoscopy. Eur Respir J. 1998 Jan;11(1):99–103. doi: 10.1183/09031936.98.11010099. [DOI] [PubMed] [Google Scholar]
  156. Ray J. F., 3rd, Lawton B. R., Myers W. O., Toyama W. M., Reyes C. N., Emanuel D. A., Burns J. L., Pederson D. P., Dovenbarger W. V., Wenzel F. J. Open pulmonary biopsy. Nineteen-year experience with 416 consecutive operations. Chest. 1976 Jan;69(1):43–47. doi: 10.1378/chest.69.1.43. [DOI] [PubMed] [Google Scholar]
  157. Remy-Jardin M., Giraud F., Remy J., Copin M. C., Gosselin B., Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology. 1993 Dec;189(3):693–698. doi: 10.1148/radiology.189.3.8234692. [DOI] [PubMed] [Google Scholar]
  158. Remy-Jardin M., Remy J., Wallaert B., Bataille D., Hatron P. Y. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology. 1993 Aug;188(2):499–506. doi: 10.1148/radiology.188.2.8327704. [DOI] [PubMed] [Google Scholar]
  159. Risk C., Epler G. R., Gaensler E. A. Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest. 1984 Jan;85(1):69–74. doi: 10.1378/chest.85.1.69. [DOI] [PubMed] [Google Scholar]
  160. Robinson D. S., Cunningham D. A., Dave S., Fleming J., Mitchell D. M. Diagnostic value of lung clearance of 99mTc DTPA compared with other non-invasive investigations in Pneumocystis carinii pneumonia in AIDS. Thorax. 1991 Oct;46(10):722–726. doi: 10.1136/thx.46.10.722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Rosenow E. C., 3rd, Myers J. L., Swensen S. J., Pisani R. J. Drug-induced pulmonary disease. An update. Chest. 1992 Jul;102(1):239–250. doi: 10.1378/chest.102.1.239. [DOI] [PubMed] [Google Scholar]
  162. Rudd R. M., Haslam P. L., Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis. 1981 Jul;124(1):1–8. doi: 10.1164/arrd.1981.124.1.1. [DOI] [PubMed] [Google Scholar]
  163. SMITH W. G. NEEDLE BIOPSY OF THE LUNG. WITH SPECIAL REFERENCE TO DIFFUSE LUNG DISEASE AND THE USE OF A NEW NEEDLE. Thorax. 1964 Jan;19:68–78. doi: 10.1136/thx.19.1.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Schmekel B., Wollmer P., Venge P., Linden M., Blom-Bülow B. Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis. Thorax. 1990 Jul;45(7):525–529. doi: 10.1136/thx.45.7.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Schwartz D. A., Helmers R. A., Galvin J. R., Van Fossen D. S., Frees K. L., Dayton C. S., Burmeister L. F., Hunninghake G. W. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):450–454. doi: 10.1164/ajrccm.149.2.8306044. [DOI] [PubMed] [Google Scholar]
  166. Schwartz D. A., Helmers R. A., Galvin J. R., Van Fossen D. S., Frees K. L., Dayton C. S., Burmeister L. F., Hunninghake G. W. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):450–454. doi: 10.1164/ajrccm.149.2.8306044. [DOI] [PubMed] [Google Scholar]
  167. Schwartz D. A., Merchant R. K., Helmers R. A., Gilbert S. R., Dayton C. S., Hunninghake G. W. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):504–506. doi: 10.1164/ajrccm/144.3_Pt_1.504. [DOI] [PubMed] [Google Scholar]
  168. Schwartz D. A., Van Fossen D. S., Davis C. S., Helmers R. A., Dayton C. S., Burmeister L. F., Hunninghake G. W. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):444–449. doi: 10.1164/ajrccm.149.2.8306043. [DOI] [PubMed] [Google Scholar]
  169. Scott J., Johnston I., Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ. 1990 Nov 3;301(6759):1015–1017. doi: 10.1136/bmj.301.6759.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Shah S. S., Tsang V., Goldstraw P. Open lung biopsy: a safe, reliable and accurate method for diagnosis in diffuse lung disease. Respiration. 1992;59(4):243–246. doi: 10.1159/000196066. [DOI] [PubMed] [Google Scholar]
  171. Sharma O. P., Johnson R. Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis. Chest. 1988 Aug;94(2):343–346. doi: 10.1378/chest.94.2.343. [DOI] [PubMed] [Google Scholar]
  172. Shorr A. F., Torrington K. G., Parker J. M. Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis. Respir Med. 1997 Aug;91(7):399–401. doi: 10.1016/s0954-6111(97)90252-3. [DOI] [PubMed] [Google Scholar]
  173. Silver R. M., Miller K. S., Kinsella M. B., Smith E. A., Schabel S. I. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med. 1990 May;88(5):470–476. doi: 10.1016/0002-9343(90)90425-d. [DOI] [PubMed] [Google Scholar]
  174. Simpson F. G., Arnold A. G., Purvis A., Belfield P. W., Muers M. F., Cooke N. J. Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax. 1986 Apr;41(4):311–317. doi: 10.1136/thx.41.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Smith C. M., Moser K. M. Management for interstitial lung disease. State of the art. Chest. 1989 Mar;95(3):676–678. doi: 10.1378/chest.95.3.676. [DOI] [PubMed] [Google Scholar]
  176. Smith D. E., Forbes A., Davies S., Barton S. E., Gazzard B. G. Diagnosis of Pneumocystis carinii pneumonia in HIV antibody positive patients by simple outpatient assessments. Thorax. 1992 Dec;47(12):1005–1009. doi: 10.1136/thx.47.12.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Smith L. S., Seaquist M., Schillaci R. F. Comparison of forceps used for transbronchial lung biopsy. Bigger may not be better. Chest. 1985 May;87(5):574–576. doi: 10.1378/chest.87.5.574. [DOI] [PubMed] [Google Scholar]
  178. Soler P., Moreau A., Basset F., Hance A. J. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Am Rev Respir Dis. 1989 May;139(5):1112–1117. doi: 10.1164/ajrccm/139.5.1112. [DOI] [PubMed] [Google Scholar]
  179. Stack B. H., Choo-Kang Y. F., Heard B. E. The prognosis of cryptogenic fibrosing alveolitis. Thorax. 1972 Sep;27(5):535–542. doi: 10.1136/thx.27.5.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Steel S. J., Winstanley D. P. Trephine biopsy of the lung and pleura. Thorax. 1969 Sep;24(5):576–584. doi: 10.1136/thx.24.5.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Steen V. D., Graham G., Conte C., Owens G., Medsger T. A., Jr Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum. 1992 Jul;35(7):765–770. doi: 10.1002/art.1780350709. [DOI] [PubMed] [Google Scholar]
  182. Suga K., Ariyoshi I., Nishigauchi K., Yoshimizu T., Nakanishi T., Utsumi H., Yamada N. Altered regional clearance of 99Tcm-DTPA in radiation pneumonitis. Nucl Med Commun. 1992 May;13(5):357–364. doi: 10.1097/00006231-199205000-00010. [DOI] [PubMed] [Google Scholar]
  183. Susskind H., Rom W. N. Lung inflammation in coal miners assessed by uptake of 67Ga-citrate and clearance of inhaled 99mTc-labeled diethylenetriamine pentaacetate aerosol. Am Rev Respir Dis. 1992 Jul;146(1):47–52. doi: 10.1164/ajrccm/146.1.47. [DOI] [PubMed] [Google Scholar]
  184. Susskind H. Technetium-99m-DTPA aerosol to measure alveolar-capillary membrane permeability. J Nucl Med. 1994 Feb;35(2):207–209. [PubMed] [Google Scholar]
  185. Taylor I. K., Coker R. J., Clarke J., Moss F. M., Nieman R., Evans D. J., Veale D., Shaw R. J., Robinson D. S., Mitchell D. M. Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-93. Thorax. 1995 Dec;50(12):1240–1245. doi: 10.1136/thx.50.12.1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Taylor J. R., Ryu J., Colby T. V., Raffin T. A. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med. 1990 Nov 1;323(18):1254–1260. doi: 10.1056/NEJM199011013231807. [DOI] [PubMed] [Google Scholar]
  187. Tazi A., Bonay M., Grandsaigne M., Battesti J. P., Hance A. J., Soler P. Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1531–1536. doi: 10.1164/ajrccm/147.6_Pt_1.1531. [DOI] [PubMed] [Google Scholar]
  188. Terriff B. A., Kwan S. Y., Chan-Yeung M. M., Müller N. L. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. Radiology. 1992 Aug;184(2):445–449. doi: 10.1148/radiology.184.2.1620845. [DOI] [PubMed] [Google Scholar]
  189. Tishler M., Grief J., Fireman E., Yaron M., Topilsky M. Bronchoalveolar lavage--a sensitive tool for early diagnosis of pulmonary involvement in rheumatoid arthritis. J Rheumatol. 1986 Jun;13(3):547–550. [PubMed] [Google Scholar]
  190. Tukiainen P., Taskinen E., Holsti P., Korhola O., Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax. 1983 May;38(5):349–355. doi: 10.1136/thx.38.5.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Tung K. T., Wells A. U., Rubens M. B., Kirk J. M., du Bois R. M., Hansell D. M. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax. 1993 Apr;48(4):334–338. doi: 10.1136/thx.48.4.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax. 1980 Mar;35(3):171–180. doi: 10.1136/thx.35.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax. 1980 Aug;35(8):593–599. doi: 10.1136/thx.35.8.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Turner-Warwick M., Haslam P. L. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis. 1987 Jan;135(1):26–34. doi: 10.1164/arrd.1987.135.1.26. [DOI] [PubMed] [Google Scholar]
  195. Turner-Warwick M., McAllister W., Lawrence R., Britten A., Haslam P. L. Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management? Thorax. 1986 Dec;41(12):903–913. doi: 10.1136/thx.41.12.903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Uebelhoer M., Bewig B., Sternberg K., Rabe K., Nowak D., Magnussen H., Barth J. Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes. Lung. 1995;173(3):187–195. doi: 10.1007/BF00175659. [DOI] [PubMed] [Google Scholar]
  197. Uh S., Lee S. M., Kim H. T., Chung Y., Kim Y. H., Park C. S. The clearance rate of alveolar epithelium using 99mTc-DTPA in patients with diffuse infiltrative lung diseases. Chest. 1994 Jul;106(1):161–165. doi: 10.1378/chest.106.1.161. [DOI] [PubMed] [Google Scholar]
  198. Unger E. R., Budgeon L. R., Myerson D., Brigati D. J. Viral diagnosis by in situ hybridization. Description of a rapid simplified colorimetric method. Am J Surg Pathol. 1986 Jan;10(1):1–8. doi: 10.1097/00000478-198601000-00001. [DOI] [PubMed] [Google Scholar]
  199. Valeyre D., Soler P., Clerici C., Pré J., Battesti J. P., Georges R., Hance A. J. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988 Jul;43(7):516–524. doi: 10.1136/thx.43.7.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Venn G. E., Kay P. H., Midwood C. J., Goldstraw P. Open lung biopsy in patients with diffuse pulmonary shadowing. Thorax. 1985 Dec;40(12):931–935. doi: 10.1136/thx.40.12.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Walker W. C., Wright V. Pulmonary lesions and rheumatoid arthritis. Medicine (Baltimore) 1968 Nov;47(6):501–520. doi: 10.1097/00005792-196811000-00003. [DOI] [PubMed] [Google Scholar]
  202. Wall C. P., Gaensler E. A., Carrington C. B., Hayes J. A. Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis. 1981 Mar;123(3):280–285. doi: 10.1164/arrd.1981.123.3.280. [DOI] [PubMed] [Google Scholar]
  203. Wallaert B., Hatron P. Y., Grosbois J. M., Tonnel A. B., Devulder B., Voisin C. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis. 1986 Apr;133(4):574–580. doi: 10.1164/arrd.1986.133.4.574. [DOI] [PubMed] [Google Scholar]
  204. Wang K. P., Wise R. A., Terry P. B., Kaplan J., Britt E. J., Haponik E. F., Summer W. R., Marsh B. Comparison of standard and large forceps for transbronchial lung biopsy in the diagnosis of lung infiltrates. Endoscopy. 1980 Jul;12(4):151–154. doi: 10.1055/s-2007-1021733. [DOI] [PubMed] [Google Scholar]
  205. Warner D. O., Warner M. A., Divertie M. B. Open lung biopsy in patients with diffuse pulmonary infiltrates and acute respiratory failure. Am Rev Respir Dis. 1988 Jan;137(1):90–94. doi: 10.1164/ajrccm/137.1.90. [DOI] [PubMed] [Google Scholar]
  206. Watters L. C., King T. E., Schwarz M. I., Waldron J. A., Stanford R. E., Cherniack R. M. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1986 Jan;133(1):97–103. doi: 10.1164/arrd.1986.133.1.97. [DOI] [PubMed] [Google Scholar]
  207. Watters L. C., Schwarz M. I., Cherniack R. M., Waldron J. A., Dunn T. L., Stanford R. E., King T. E. Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis. 1987 Mar;135(3):696–704. doi: 10.1164/arrd.1987.135.3.696. [DOI] [PubMed] [Google Scholar]
  208. Weinberger S. E., Kelman J. A., Elson N. A., Young R. C., Jr, Reynolds H. Y., Fulmer J. D., Crystal R. G. Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med. 1978 Oct;89(4):459–466. doi: 10.7326/0003-4819-89-4-459. [DOI] [PubMed] [Google Scholar]
  209. Wells A. U., Hansell D. M., Harrison N. K., Lawrence R., Black C. M., du Bois R. M. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J. 1993 Jun;6(6):797–802. [PubMed] [Google Scholar]
  210. Wells A. U., Hansell D. M., Rubens M. B., Cullinan P., Black C. M., du Bois R. M. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1076–1082. doi: 10.1164/ajrccm/148.4_Pt_1.1076. [DOI] [PubMed] [Google Scholar]
  211. Wells A. U., Hansell D. M., Rubens M. B., Cullinan P., Haslam P. L., Black C. M., Du Bois R. M. Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med. 1994 Aug;150(2):462–468. doi: 10.1164/ajrccm.150.2.8049830. [DOI] [PubMed] [Google Scholar]
  212. Westcott J. L. Air embolism complicating percutaneous needle biopsy of the lung. Chest. 1973 Jan;63(1):108–110. doi: 10.1378/chest.63.1.108. [DOI] [PubMed] [Google Scholar]
  213. Wetstein L. Sensitivity and specificity of lingular segmental biopsies of the lung. Chest. 1986 Sep;90(3):383–386. doi: 10.1378/chest.90.3.383. [DOI] [PubMed] [Google Scholar]
  214. White D. A., Stover D. E. Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids. Chest. 1984 Nov;86(5):723–728. doi: 10.1378/chest.86.5.723. [DOI] [PubMed] [Google Scholar]
  215. Wiggins J., Strickland B., Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med. 1990 Sep;84(5):365–369. doi: 10.1016/s0954-6111(08)80070-4. [DOI] [PubMed] [Google Scholar]
  216. Winterbauer R. H., Hutchinson J. F. Use of pulmonary function tests in the management of sarcoidosis. Chest. 1980 Oct;78(4):640–647. doi: 10.1378/chest.78.4.640. [DOI] [PubMed] [Google Scholar]
  217. Winterbauer R. H., Lammert J., Selland M., Wu R., Corley D., Springmeyer S. C. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest. 1993 Aug;104(2):352–361. doi: 10.1378/chest.104.2.352. [DOI] [PubMed] [Google Scholar]
  218. Wollmer P., Evander E. Biphasic pulmonary clearance of 99mTc-DTPA in smokers. Clin Physiol. 1994 Sep;14(5):547–559. doi: 10.1111/j.1475-097x.1994.tb00413.x. [DOI] [PubMed] [Google Scholar]
  219. Youmans C. R., Jr, De Groot W. J., Marshall R., Morettin L. B., Derrick J. R. Needle biopsy of the lung in diffuse parenchymal disease An analysis of 151 cases. Am J Surg. 1970 Nov;120(5):637–643. doi: 10.1016/s0002-9610(70)80184-2. [DOI] [PubMed] [Google Scholar]
  220. Zavala D. C., Bedell G. N. Percutaneous lung biopsy with a cutting needle. An analysis of 40 cases and comparison with other biopsy techniques. Am Rev Respir Dis. 1972 Aug;106(2):186–193. doi: 10.1164/arrd.1972.106.2.186. [DOI] [PubMed] [Google Scholar]
  221. Zavala D. C. Pulmonary hemorrhage in fiberoptic transbronchial biopsy. Chest. 1976 Nov;70(5):584–588. doi: 10.1378/chest.70.5.584. [DOI] [PubMed] [Google Scholar]
  222. Zavala D. C. Transbronchial biopsy in diffuse lung disease. Chest. 1978 May;73(5 Suppl):727–733. doi: 10.1378/chest.73.5_supplement.727. [DOI] [PubMed] [Google Scholar]
  223. Zwirewich C. V., Mayo J. R., Müller N. L. Low-dose high-resolution CT of lung parenchyma. Radiology. 1991 Aug;180(2):413–417. doi: 10.1148/radiology.180.2.2068303. [DOI] [PubMed] [Google Scholar]
  224. al Jarad N., Gellert A. R., Rudd R. M. Bronchoalveolar lavage and 99mTc-DTPA clearance as prognostic factors in asbestos workers with and without asbestosis. Respir Med. 1993 Jul;87(5):365–374. doi: 10.1016/0954-6111(93)90050-a. [DOI] [PubMed] [Google Scholar]
  225. du Bois R. M. Diffuse lung disease: an approach to management. BMJ. 1994 Jul 16;309(6948):175–179. doi: 10.1136/bmj.309.6948.175. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES